U.S. Markets closed

Corbus Pharmaceuticals (CRBP) in Focus: Stock Moves 10% Higher

Zacks Equity Research

Corbus Pharmaceuticals Holdings, Inc.CRBP was a big mover last session, as the company saw its shares rise 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $6.55 to $7.45 in the past one-month time frame.

The move came after the company reported positive results from a 16-week Phase 2 study of its autoimmune disease drug. 

The company has seen a mixed track record when it comes to estimate revision of one increase and no decrease over the past few months, while the Zacks Consensus Estimate for the current quarter has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Corbus Pharmaceuticals Holdings, Inc. Price

Corbus Pharmaceuticals Holdings, Inc. Price | Corbus Pharmaceuticals Holdings, Inc. Quote

Corbus Pharmaceuticals currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP  is 0.00%.

Another stock worth considering in the Medical sector is MEI Pharma, Inc. MEIP which carries a Zacks Rank #1.You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CRBP going up? Or down? Predict to see what others think: Up or Down

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MEI Pharma, Inc. (MEIP) : Free Stock Analysis Report
Corbus Pharmaceuticals Holdings, Inc. (CRBP) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research